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Abstract
The long isoform of Fas apoptosis inhibitory molecule (FAIM-L) is a neuron-specific death receptor antagonist that
modulates apoptotic cell death and mechanisms of neuronal plasticity. FAIM-L exerts its antiapoptotic action by
binding to X-linked inhibitor of apoptosis protein (XIAP), an inhibitor of caspases, which are the main effectors of
apoptosis. XIAP levels are regulated by the ubiquitin-proteasome pathway. FAIM-L interaction with XIAP prevents the
ubiquitination and degradation of the latter, thereby allowing it to inhibit caspase activation. This interaction also
modulates non-apoptotic functions of caspases, such as the endocytosis of AMPA receptor (AMPAR) in hippocampal
long-term depression (LTD). The molecular mechanism of action exerted by FAIM-L is unclear since the consensus
binding motifs are still unknown. Here, we performed a two-hybrid screening to discover novel FAIM-L-interacting
proteins. We found a functional interaction of SIVA-1 with FAIM-L. SIVA-1 is a proapoptotic protein that has the capacity
to interact with XIAP. We describe how SIVA-1 regulates FAIM-L function by disrupting the interaction of FAIM-L with
XIAP, thereby promoting XIAP ubiquitination, caspase-3 activation and neuronal death. Furthermore, we report that
SIVA-1 plays a role in receptor internalization in synapses. SIVA-1 is upregulated upon chemical LTD induction, and it
modulates AMPAR internalization via non-apoptotic activation of caspases. In summary, our findings uncover SIVA-1 as
new functional partner of FAIM-L and demonstrate its role as a regulator of caspase activity in synaptic function.
Introduction
Apoptosis plays a crucial role during neural develop-
ment and adult life1,2. The main orchestrators of apoptosis
are caspases, effector proteases that mediate the proteo-
lytic cascade that ultimately leads to cell death. Several
non-apoptotic functions of caspases have been reported in
neurons2. Localized activation of caspases has been
described as necessary in the physiological context of
neuronal pruning, axon guidance, and synaptic plasticity3.
The activation of caspase-3 via mitochondria is required
for AMPA receptor (AMPAR) internalization in NMDA
receptor-dependent long-term depression (LTD). Several
studies have shown that LTD is abolished in caspase-3
knock-out mice4, and caspase-3-deficient neurons in cul-
ture fail to show spine shrinkage in response to NMDA
stimulation (chemical LTD)5.
FAIM-L is the neuron-specific isoform of FAIM, and it
harbors 22 additional amino acids at the N-terminal as
compared to FAIM-S. We have previously shown that
FAIM-L regulates caspase activation in neurons. Moreover,
decreased FAIM-L levels have been associated with the
progression of Alzheimer’s disease (AD), an irreversible and
progressive neurodegenerative disorder that is the most
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common cause of dementia6. AD is characterized by neu-
ronal death and the dysregulation of synaptic plasticity7,
mechanisms in which FAIM-L and apoptotic pathways are
involved and have been shown to play crucial roles.
FAIM-L modulates death receptor-induced cell death by
interacting with death receptors8 and by interacting and
stabilizing the X-linked inhibitor of apoptosis protein
(XIAP). XIAP is a key member of the inhibitor of apoptosis
protein family that directly binds to and inhibits effector
caspases. XIAP levels are regulated by a process of auto-
ubiquitination and proteasome degradation. Given its anti-
apoptotic role, modification of XIAP levels is a decisive step
in cell death induction9. FAIM-L confers neurons additional
protection against cell death. In fact, FAIM-L interacts with
XIAP and inhibits its ubiquitination and degradation by the
proteasome, therefore maintaining the role of XIAP in
preventing the cleavage and activation of caspases10. FAIM-
L also participates in processes where caspases play a non-
apoptotic role. By stabilizing XIAP levels, FAIM-L prevents
AMPAR internalization after chemical induction of LTD
(chLTD) in vitro and protects axons from degeneration
induced by growth-factor deprivation11.
Structural prediction algorithms for FAIM-L do not
identify any functional domain that could predict potential
protein association, and apart from XIAP, no other FAIM-
L-interacting protein has been described to date. Here,
using a yeast two-hybrid screening approach, we screened
for potential FAIM-L partners of relevance for its function.
Using either the full-length or the specific N-terminal
amino acid sequence of FAIM-L as bait, we identified the
proapoptotic SIVA-1 protein as a FAIM-L binding partner.
SIVA-1 has been described as a proapoptotic protein,
capable of inducing cell death in several cellular models12.
Moreover, SIVA-1 has been reported to interact with
XIAP13. Apoptotic induction mediated by SIVA-1 has been
proposed to occur through several pathways, and it is
essential for p53-induced apoptosis in granular neurons14.
Here, we studied the contribution of SIVA-1 to the roles of
FAIM-L and XIAP in caspase-dependent apoptotic and
non-apoptotic functions in neurons. We found that SIVA-1
blocks the antiapoptotic function of FAIM-L by displacing
the XIAP/FAIM-L interaction, thereby inducing XIAP
degradation, caspase-3 activation and subsequent neuronal
death or AMPAR internalization. Our results point to
SIVA-1 as one of the proteins of the apoptotic machinery
able to modulate caspase-3 activation in response to
synaptic plasticity. On the basis of our findings, SIVA-1
emerges as a novel synaptic modulator.
Material and methods
Reagents
Unless otherwise specified, all biochemical reagents
were purchased from Sigma-Aldrich.
Yeast two-hybrid screen
The pACT2-mouse cDNA library in Escherichia coli
(Clontech cat# ML4008AH/cat# 638841) was pre-
transformed in the yeast AH109 strain (more than 107
independent clones). The full-length FAIM-L and the 22
additional amino acids at the N-terminal FAIM isoform
(FAIM-L) bait proteins were subcloned into pGBKT7
vector and transformed in Y187 yeast strain. The two-
hybrid selection was performed by mating, following the
matchmaker two-hybrid system 3 protocol (cat# K1612-1
Clontech). Positive colonies were selected in drop out
medium lacking leucine, tryptophan, and histidine and
containing 20mM aminotriazole. Colonies were analyzed
by polymerase chain reaction (PCR). cDNA was
sequenced and transformed in E. coli (WB Cat# OP50),
and interactions of bait and prey were confirmed by back
transformation in yeast.
Cell culture
HEK293T cells (ATCC Cat# CRL-3216) were grown
in DMEM supplemented with 10% heat-inactivated
fetal bovine serum (iFBS) (Invitrogen), 20 U/ml peni-
cillin and 20 µg/ml streptomycin. Rat pheochromocy-
toma PC12 cells (ATCC Cat# CRL-1721) were grown in
DMEM supplemented with 6% iFBS, 6% heat inacti-
vated horse serum (iHS), 10 mM HEPES, 20 U/ml
penicillin and 20 µg/ml streptomycin. Cultures were
maintained at 37 °C in a 5% CO2 atmosphere in a
humidified incubator.
Primary neuron cultures
Neuron cultures were prepared from wild-type C57BL/
6J mice (Envigo, France) at embryonic day 15–16
(E15–16). Cerebral cortices and hippocampi were dis-
sected in phosphate-buffered saline (PBS) pH 7.4. After
trypsin and DNase treatment, tissues were mechanically
dissociated and filtered through a 40-µm nylon mesh.
Cells were resuspended in DMEM supplemented with 5%
iFBS, 5% iHBS, 20 U/ml penicillin and 20 µg/ml strepto-
mycin. Cells were then plated in poly-D-lysine-coated
plates at a density of 3 × 105 cells/ml or on coverslips at
1.5 × 105 cells/ml for immunocytochemistry experiments.
Four hour after seeding, medium was replaced by Neu-
robasal medium supplemented with B27, glutaMAX (Life
Tech), 20 U/ml penicillin and 20 µg/ml streptomycin.
Culture medium was partially replaced every 3–4 days
with fresh medium. Cultures were kept at 37 °C in a 5%
CO2 atmosphere in a humidified incubator. When pan-
caspase inhibitor quinolyl-Val-Asp-OPh (Q-VD) treat-
ment was performed, Q-VD was added directly to culture
media at a final concentration of 10 µM. All experimental
protocols were approved by the Vall d’Hebron Institu-
tional Review Board.
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Plasmids
The constructions used for this study, namely 3xHA-
SIVA-1, 3xHA-ΔSIVA-1, 3xFLAG-FAIM-L, 3xHA-
FAIM-L, 6xMyc-XIAP and YFP, were expressed under
the control of a cytomegalovirus constitutive promoter in
the pcDNA3 expression vector (Invitrogen). 3xFLAG-
SIVA-1 plasmid was kindly provided by Dr. Ulrike Resch
(Medical University of Vienna). Lentiviral plasmids for
this study were cloned into pEIGW. Short hairpin RNA
(shRNA) targeting SIVA-1 was cloned into the pLVTHM
vector, and a scrambled sequence was used as a control.
Lentiviral production
Lentiviruses were produced as described previously by
Segura et al.8. For infection, lentiviruses were added to the
host cell medium. Infection efficiency was monitored by
counting green fluorescent protein (GFP)-positive cells.
Cell transfection and infection
HEK293T (ATCC Cat# CRL-3216) or PC12 (ATCC
Cat# CRL-1721) cells were transfected with the desired
expression plasmid using the calcium phosphate method
or Lipofectamine 2000 (Invitrogen), following the manu-
facturer’s instructions. The total amount of transfected
DNA was kept constant by adding empty pcDNA3
expression vector. Primary neurons were transfected with
Lipofectamine 2000, as described in Dalby et al.15.
Immunoprecipitation
After 24–48 h of transient transfection for ectopic
expression, or after 24 h in culture, HEK293T and PC12
cells were rinsed in PBS 1× and lysed in immunopreci-
pitation lysis buffer (IP lysis buffer) containing 20mM
Tris/HCl, pH 7.4, 150mM NaCl, 2 mM EDTA, 10%
Glycerol, 1% Triton X-100, and supplemented with a
protease inhibitor cocktail (Roche). Samples were lysed
for 30min on ice and centrifuged at 4 °C at 12,000 × g.
One milligram of total protein was used for immuno-
precipitation overnight at 4 °C in an orbital shaker. Spe-
cific FLAG M2 Affinity monoclonal agarose beads or anti-
ubiquitin-conjugated agarose beads (Santa Cruz Bio-
technology Cat# sc-8017 AC) were used for IP:FLAG and
IP:Ubiquitin respectively. For IP:Myc, lysates were pre-
cleared by 30 min of incubation with 20 µl conjugated
protein G suspension and 0.25 µg/µl control mouse IgG.
Afterwards, 1 µg Myc antibody (Santa Cruz Biotechnology
Cat# sc-40) was added to each sample and incubated for
4 h at 4 °C in an orbital shaker. Finally, 20 µl conjugated
protein G suspension was added and incubated overnight
on an orbital shaker. After incubation, agarose beads were
washed five times with IP lysis buffer and eluted. Elution
was performed with a competitor peptide for IP:FLAG
and IP:Myc, following the manufacturer’s protocol. For IP:
Ubiquitin, elution was performed by adding Laemmli
buffer (60 mM Tris/HCL 1M, pH 6.8, 2% sodium dodecyl
sulfate (SDS), 10% Glycerol, 0.01% Bromophenol Blue)
without dithiothreitol and boiling samples at 95 °C for
5 min. Whole-cell lysate and immunoprecipitated pro-
teins were then analyzed by western blot.
Immunohistochemistry
E16, P0, P5, P15, and adult OF-1 mice (Charles River,
Lyon; France) were used for immunohistochemistry
experiments. The day the vaginal plug was detected was
considered embryonic day 0 (E0), and the day of birth as
postnatal day 0 (P0). First, the animals were deeply
anesthetized with a Ketolar (Parke-Davies/Pfizer New
York, NY; USA)/Rompun (Bayer AG, Leverkusen; Ger-
many) mixture and perfused with 4% paraformaldehyde
in 0.1 M phosphate buffer. Brains were dissected, cryo-
protected and frozen. Next, 30–50 μm coronal sections
were obtained. After blocking, sections were incubated
overnight with specific rabbit antibody against SIVA-1
(dilution 1:100, Santa Cruz Biotechnology Cat# sc-
48768) or mouse anti-SIVA-1 (dilution 1:100, Sigma-
Aldrich Cat#SAB1400393). These primary antibodies
were visualized by sequential incubation with biotiny-
lated secondary antibodies (dilution 1:200, Vector Labs
Burlingame, CA; USA) and the streptavidin–peroxidase
complex (dilution 1:400, Amersham Biosciences Pitts-
burgh, PA, USA). The peroxidase reaction was devel-
oped with diaminobenzidine (DAB) and H2O2. The
sections were mounted onto gelatinized slides, and then
dehydrated and cover-slipped with Eukkit (Panreac).
Sections from E16, P5, P15, and adult mice were used for
double immunofluorescence studies. Sections were incu-
bated overnight with the specific antibody detecting SIVA-1
(dilution 1:100, Santa Cruz Biotechnology, Cat# sc-48768)
combined with antibodies against neuron-specific nuclear
protein (NeuN, dilution 1:100, Millipore Cat# MAB377),
PV (dilution 1:3000, Swant Antibodies Cat# PVG-214,
RRID:AB_2313848) or GFAP (dilution 1:500, Millipore
Cat# AB5804). Primary antibodies were visualized using
secondary Alexa Fluor-conjugated antibodies. Sections were
mounted with Prolong diamond mounting medium
(Thermo Fisher) and viewed under a confocal microscope.
Immunocytochemistry
Hippocampal or cortical primary neurons were cul-
tured on glass coverslips pre-coated with 10 µg/ml poly-
D-lysine. After 7–10 days in vitro (DIV), cells were fixed
with 4% paraformaldehyde for 30 min at room tem-
perature. Permeabilization and blocking were carried
out with a permeabilization solution (PS) containing 5%
FBS, 5% bovine serum albumin, and 0.1% Triton-X for
1 h at room temperature, followed by incubation with
primary antibodies in PS overnight at 4 °C. The follow-
ing primary antibodies were used: anti-SIVA-1 (dilution
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1:500 Santa Cruz Biotechnology Cat# sc-48768; Sigma-
Aldrich Cat# SAB1400393); anti-SIVA-1 (dilution 1:25,
Sigma-Aldrich Cat# SAB3500697), anti-XIAP (dilution
1:25, BD Cat# 610762), anti-HA (dilution 1:100, Roche
Cat# 1-867-423); anti-Rab5 (dilution 1:500, Cell Sig-
naling Technology Cat# 2143); anti-Calnexin (dilution
1:500, Cell Signaling Technology Cat# 2433S); anti-βIII
Tubulin (dilution 1:1000, Covance Research Products
Inc Cat# SIG-3840-1000); anti-TrkA (dilution 1:1000, in
house); anti-PSD95 (dilution 1:200, Cell Signaling Cat#
3450); anti-Synapsin II (dilution 1:200, Enzo Life Sci-
ence Cat# ADI-VAS-SV061-E); and anti-GFP (1:2000,
Abcam Cat# ab6556). Subsequently, cells were rinsed
with PBS and incubated with fluorescent-conjugated
secondary antibodies (dilution 1:400–1:1000, Alexa-
Fluor Thermo Fisher Scientific Cat# A-11001 Cat# A-
11912) diluted in PS for 1 h at room temperature. Prior
to the last wash, cells were incubated for 30 min at room
temperature with Hoechst 33258 (0.05 µg/ml) to stain
nuclear DNA. MitoTracker staining (Invitrogen) was
used, following the manufacturer’s instructions. Cover-
slips were finally mounted on slides with Prolong dia-
mond mounting medium (Thermo Fisher).
Cell death quantification
At 4 days post infection, primary neurons were fixed
with 2% paraformaldehyde, permeabilized with 0.1% Tri-
ton™ X-100 and stained with Hoechst 33342 (0.05 µg/ml).
Apoptosis was assessed by counting viable and dead cells,
discriminating condensed and fragmented nuclei (apop-
totic nuclear morphology type II)16. For each experiment
quantification was performed in blind testing, and at least
500 cells were counted per condition.
Caspase activity assay
The caspase activity assay was performed as previously
described by Galenkamp et al.17. Briefly, primary neurons
were harvested and lysed in caspase activity buffer (20mM
HEPES-NaOH, pH7.2, 10% sucrose, 150mM NaCl, 5mM
EDTA, 1% Igepal CA-630, 0.1% CHAPS, and 1× EDTA-free
complete protease inhibitor cocktail). Next, 20 µg protein
was incubated at 37 °C in caspase activity buffer supple-
mented with 10mM DTT and 50 µM of the fluorogenic
substrate Ac-DEVD-Afc (Merck Millipore). Plates were
read in a fluorometer using excitation and emission wave-
lengths of 405 and 535 nm, respectively.
Subcellular protein fractionation
Subcellular fractionation was performed as previously
described18. Adult mouse brains were homogenized in
buffer containing 10mm HEPES, pH 7.4, 2 mm EDTA,
0.32M sucrose, and protease inhibitor cocktail (Roche).
Cell homogenates were centrifuged sequentially at 600 × g
for 10 min to remove nuclei (N) and unbroken cells, then
at 3000 × g for 10 min to pellet the plasma membrane
(PM) and collect cytosolic fractions (supernatant). Nuclei
were extracted from the 600 × g pellet with centrifuga-
tions at 500 × g for 15 min. The supernatants were cen-
trifuged twice at each speed, and pellets were washed
twice by resuspension in homogenization buffer and
recentrifugation. Pellets were lysed in SET buffer (10 mM
Tris-HCl pH7.4, 1 mM EDTA, 150mM NaCl, 1% SDS).
Protein concentration was quantified by a modified Lowry
assay (DC protein assay; Bio-Rad, Hercules, CA). Samples
were heat-denatured in Laemmli buffer and subjected to
SDS polyacrylamide gel electrophoresis.
Western blot
Cells were harvested and lysed in SET buffer. Protein
concentration was quantified by a modified Lowry assay
(DC protein assay; Bio-Rad, Hercules, CA, USA). Lysates
were prepared with Laemmli buffer (60 mM Tris/HCl
1M pH 6.8, 2% SDS, 100mM glycerol, 0.01% Bromo-
phenol Blue), resolved in SDS polycramide gels, and
transferred onto polyvinylidene fluoride Immobilon-P
membranes (Merck Millipore). After blocking with TBS
1× −0.1% Tween-20 containing 5% nonfat dry milk for
1 h at room temperature, membranes were probed with
the appropriate primary antibodies, prior to incubation
for 1 h with the appropriate specific peroxidase-
conjugated secondary antibody. Membranes were devel-
oped using the EZ-ECL chemiluminescence detection kit
(Biological Industries, Kibbutz Beit Haemek, Israel). The
following primary antibodies were used: anti-FAIM-L
(dilution 1:2000, in house); anti-caspase-3 (dilution
1:1000, Cell Signaling Technologies Cat# 9662); anti-pan
ERK (dilution 1:10000, BD Bioscience Cat# 610123); anti-
β-actin (dilution 1:2000, Santa Cruz Biotechnology Cat#
sc-47778); anti-alpha-tubulin (dilution 1:50000, Sigma-
Aldrich Cat# T5168); anti-XIAP (dilution 1:5000, BD
Bioscience Cat# 610762); anti-FLAG (dilution 1:10000,
Sigma-Aldrich Cat# F3165); anti-HA (dilution 1:5000,
Roche Cat# 11867423001); anti-SIVA-1 (dilution 1:500,
Sigma Cat# SAB3500697); anti-GluA2 (1:1000, Millipore
Cat# MAB397); anti-cytochromec (1:1000, BDbioscience
Cat# 556433); anti-calnexin (1:1000, Abcam Cat#
ab31290); anti-histone-3 (1:1000, Cell Signaling Tech-
nologies Cat# 9715); and anti-GAPDH (1:2000, Abcan
Cat# ab9485).
Chemical LTD induction
Primary neurons were treated at 12–14 DIV with 50 µM
N-methyl-D-aspartate (NMDA) for 15min at 37 °C to
induce chLTD as described in Li et al.4. Fifty micromolar
of BAPTA-AM was used as calcium chelator and 1 µg/ml
of cycloheximide (CHX) as an inhibitor of protein trans-
lation. Cells were pretreated with BAPTA-AM or CHX
during 30 or 60min, respectively. Treatments were added
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to media for the pretreatment and maintained during
chLTD induction.
GluA2 internalization assay and surface staining
Internalization assays were performed as described in
Martinez-Marmol et al.11, with minor modifications.
Hippocampal neurons at 12–14 DIV were incubated with
antibodies against the N-terminus of GluA2 (2 µg/ml,
mouse monoclonal, clone 6C4, Millipore Cat# MAB397)
for 60min at 20 °C. They were then either stimulated with
medium containing NMDA (50 µM) for 15min at 37 °C
or left unstimulated. Subsequently, they were fixed for
5 min at room temperature in paraformaldehyde:sucrose
in PBS. Surface-remaining antibody-labeled receptors
were visualized by means of a 1 h incubation with satu-
rated AlexaFluor-647 secondary antibody (15 µg/ml,
Abcam Cat# ab150115). Neurons were then permeabi-
lized for 2 min with methanol (−20 °C), and internalized
antibody-labeled GluA2 was detected by a 1 h incubation
with Alexa 568-conjugated secondary antibody (1 µg/ml;
Molecular Probes Cat# A-11004). Simultaneously, infec-
ted GFP-positive or HA-positive neurons were stained
with antibodies against GFP (5 µg/ml, Abcam; Cat#
ab6556) or HA (10 µg/ml Roche Cat# 11867423001),
respectively. Thus, the GFP fluorescence of infected
neurons was enhanced by a 30min incubation with Alexa
488-conjugated secondary antibody (4 µg/ml; Thermo
Fisher Scientific Cat# A27034). After three washes in PBS
1×, the coverslips were mounted on slides with Prolong
diamond mounting medium (Thermo Fisher).
Image acquisition and analysis
Images were acquired with a confocal laser scanning
microscope (spectral FV1000; Olympus). The digital
images were processed using the FIJI software (Fiji)19.
Protein co-localization in the dual-color confocal ima-
ges was measured quantitatively using the JACoP Plug-in
(http://fiji.sc/wiki/index.php/Colocalization_Analysis).
Co-localization was determined by Pearson’s and Man-
ders co-localization coefficients. Briefly, Pearson’s coeffi-
cient values describe the relationship between two image
signals calculated by linear regression. Values can range
from 1 to −1, with 1 standing for complete positive cor-
relation and −1 for complete negative correlation. Man-
ders co-localization coefficients (M1 and M2) describe the
contribution of two selected channels to the pixels of
interest, in this case Channel 1 being SIVA-1 and Channel
2 the other markers. Each coefficient represents the
fraction of one channel signal that coincides with the
signal of the other channel. Manders co-localization
coefficients values range from 0 (uncorrelated distribu-
tions of two probes with one another) to 1 (perfect co-
localization of two images)20. At least 15 cells were con-
sidered for quantification.
For GluA2 internalization and surface staining, a z-stack
of images was obtained through various filter channels
(Alexa-488, Alexa-568 and Alexa-674). Typically, 25 serial
2D images were recorded at 45-nm intervals. Image
acquisition settings were identical in each experiment. FIJI
software was used to make 2D projections from the z-
stack of images. We measured the total integrated
intensity of internalized GluA2 and surface-remaining
GluA2 in the same region of infected (GFP/HA-positive)
neurons. For each experiment at least 15–20 cells were
counted per condition.
Cell surface biotinylation
Cell surface proteins were biotinylated and isolated using
the Pierce® Cell Surface Protein Isolation Kit (Thermo
Fisher Scientific), following the manufacturer’s instructions.
Before immunoprecipitation, the amount and concentra-
tion of protein were equalized by Lowry quantification.
RNA extraction and quantitative reverse transcription PCR
Total RNA was isolated from cells using the RNeasy
Mini Kit (Qiagen), following the manufacturer’s protocol.
cDNA was reverse-transcribed using the High-Capacity
cDNA Reverse Transcription Kit (Thermo Fisher). SIVA-
1 mRNA expression was measured with SYBR green
(Applied Biosystems) and normalized against L27 using
the following primers: SIVA-1 forward: 5′-GATCACAT
ATCGAGCGAAGA-3′, reverse: 5′-GCCTTCCCATCCA
CAGATCT-3′; and L27: forward: 5′-AGCTGTCATCG
TGAAGAA-3′, reverse: 5′-CTTGGCGATCTTCTTCTT
GCC-3′. Analysis was performed using the 7900HT
Sequence Detection System 2.3 Software (Applied Bio-
systems). Relative expression fold change was determined
by the comparative 2(−ΔΔCT) method21.
Experimental design and statistical analysis
All results were confirmed in at least three independent
experiments. Representative images and western blots are
shown in figures, while measurements of all repeated
experiments are measured in graphs. Data sets were
plotted and analyzed using GraphPad Prism v5 (GraphPad
Software; La Jolla, CA, USA). Values were excluded using
the analysis to identify outliers included in the software.
Values are expressed as mean ± SEM. Statistical sig-
nificance was set at p < 0.05 and was determined by two-
tailed unpaired t test for comparisons between two
groups, or by two-way ANOVA for multiple groups. Each
specific test is indicated in figure legends.
Results
SIVA-1 interacts with FAIM-L
To identify the functional partners of FAIM-L, we
performed a yeast-two-hybrid screening using as bait the
full-length sequence of FAIM-L or the 22 N-terminal-
Coccia et al. Cell Death and Disease           (2020) 11:82 Page 5 of 19
Official journal of the Cell Death Differentiation Association
specific amino acids of this isoform. Among the top six
hits shown in Table 1, the N-terminal fragment of SIVA-1
was detected (ΔSIVA-1) (Table 1 and Fig. 1a).
We validated this interaction in HEK 293T cells by co-
immunoprecipitation experiments using full-length FLAG-
tagged FAIM-L, HA-tagged N-terminal SIVA-1 (ΔSIVA-1),
or HA-tagged full-length SIVA-1. We confirmed the
interactions between FAIM-L and both full-length and
ΔSIVA-1 forms (Fig. 1b, lanes 3 and 6). Interaction with the
truncated form of SIVA-1 was detected only in the presence
of the proteasome inhibitor MG132 (Fig. 1b, lane 6),
otherwise it was not stable and was consequently degraded.
Our group reported XIAP as a FAIM-L-interacting
partner10. XIAP is an inhibitor of caspases and its endo-
genous levels are crucial for FAIM-L protection against
caspase activation and consequent apoptotic or non-
apoptotic functions10,11. Since Resch and colleagues
described an interaction between SIVA-1 and XIAP13, we
performed co-immunoprecipitation experiments and cor-
roborated that XIAP does indeed interact with both FAIM-
L and SIVA-1 (Fig. 1c).
To detect the interaction in a semi-endogenous condi-
tion, we transfected primary cortical neurons with 3xHA-
FAIM-L. We then performed immunocytochemistry
against HA, endogenous SIVA-1 and XIAP (Fig. 1d). Co-
localization analysis revealed partial correlation of signals
of SIVA-1 with both XIAP (Pearson’s correlation value
R= 0.412 ± 0.115) and HA-FAIM-L (Pearson’s correlation
R= 0.607 ± 0.060). We could also observe that the
interactions between SIVA-1, XIAP and tagged FAIM-L
takes place in neuronal cytoplasm.
SIVA-1 is expressed in neurons
FAIM-L expression is restricted to neurons8. To under-
stand the biological context in which SIVA-1 may modulate
FAIM-L functions, we first examined SIVA-1 expression in
mouse brain tissue. Histological analysis showed that SIVA-
1 expression occurred in most brain regions throughout
development (Fig. 2a–h, stages E16-adult mouse). High
levels were detected in the telencephalon (cerebral cortex
and hippocampus) and in the cerebellum (Fig. 2e–h). In the
embryonic cerebral cortex, labeled cells were located in the
cortical plate (CP) and in the subplate (SP), corresponding to
postmitotic neurons of these layers (Fig. 2a). At postnatal
stages (P0-P15), SIVA-1-positive cells were found through-
out the cortical layers, the strongest staining being detected
in layers II–III (Fig. 2b, c). At adult stages, the expression of
SIVA-1 in the cerebral cortex appeared to be restricted to
layer V cortical neurons (Fig. 2d). The cerebellum also
showed intense SIVA-1-immunolabeling (Fig. 2e–g). SIVA-
1 was expressed in migratory Purkinje cells in the embryonic
cerebellum (data not shown). At postnatal P10 and
P15 stages, cell bodies and dendrites of Purkinje neurons
showed intense SIVA-1-immunostaining (Fig. 2e). These
neurons maintained SIVA-1 expression at later stages and
also during adulthood (Fig. 2g). At embryonic stages, cells in
the hippocampal plate expressed SIVA-1 (data not shown).
At postnatal stages, pyramidal neurons in CA1–3 and some
Table 1 Yeast two-hybrid analysis. List of protein–protein interactions with full-length FAIM-L and the 22 N-terminal-
specific amino acids of the FAIM-L isoform.
Yeast two-
hybrid analysis
Bait Sequence
pGBKT7
(control)
pGBKT7- full
length FAIM-L
pGBKT7-N-term
FAIM-L -(MASGDD
SPIFEDDESPPYSLEK)
SIVA-1 (ΔSIVA-1) − + + MPKRSCPFADAAPLQLKVHVGLKELSHGVFAERYSREV
FERM RhoGEF − + + HELKKDLIGIDNLVTPGREFIRLGSLSKLSGKGLQQRMFFLFNDVLLYTS
RGLTASNQFKVHGQLPLYGMTIEESEEEWGVPHCLTLRGQRQSIIVAA
SSRSEMEKWMEDIQMAIDLAEKSNGPTPELLASSPPDNKSPDEA
GAPDH − + + YSNRMVDLMAYMASKE
COMMD1 − + + EGGKSLSGLLSGLAQNAFHGHSGVTEELLHSQLYPEVPPEEFRPFLA
KMRGLLKSIASADMDFNQLEAFLTAQTKKQGGITSEQAAVISKFWKSH
KIKIRESLMKQSRWDNGLRGLSWRVDGKSQSRHSTQIHSPVAIIELEFG
KNGQESEFLCLEFDEVKVKQILKKLSEVEESINRLMQAA
Calcyclin − + + DKFVKIYITLTGVHQVPTENVQVHFTERSFDLLVKNLNGKNYSMIVNN
LLKPISVESSSKKVKTDTVIILCRKKAENTRWDYLTQVEKECKEKE
AP2m1 − + + PKRACQFNRTQLGDCSGIGDPTHYGYSTGQPCVFIKMNRVINFYAGAN
QSMNVTCVGKRDEDAENLGHFVMFPANGSIDLMYFPYYGKKFHVNY
TQPLVAVKFLNVTPNVEVNVECRINAANIATDDERDKFAGRVAFKLRINKT
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Fig. 1 SIVA-1 interacts with FAIM-L and XIAP. a Schematic representation of the two-hybrid technique results. The N-terminal of SIVA-1(ΔSIVA-1)
interacted with both baits, namely full-length FAIM-L and FAIM-L-specific N-terminal 22 amino acids. b Immunoprecipitation in HEK 293T cells of
FLAG-FAIM-L using M2 Affinity FLAG. FAIM-L was immunoprecipitated and membrane was blotted with anti-HA to detect full-length SIVA-1 and
ΔSIVA-1. Ten micromolar of MG132 (proteasome inhibitor) was used to impair the degradation of ΔSIVA-1. c Immunoprecipitation of Myc-XIAP using
anti-Myc antibody. Cells were transiently transfected with Myc-XIAP, FLAG-FAIM-L, and FLAG-SIVA-1. The membrane was blotted with anti-FLAG to
detect both FAIM-L and SIVA-1. XIAP was used as a control of the immunoprecipitation and actin as loading control. d Representative confocal
images of immunocytochemistry in cortical neurons. Neurons were transfected with HA-tagged FAIM-L at 4 days in vitro. Forty-eight hour after
transfection, immunofluorescence was performed staining with anti-SIVA-1 (green), anti-HA (to detect HA-FAIM-L, red), and anti-XIAP (blue). Scale bar
10 µm. Graph reports Pearson’s correlation coefficients obtained in co-localization analysis (SIVA-1/HA-FAIM-L R= 0.607 ± 0.060; SIVA-1/XIAP R=
0.412 ± 0.115).
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interneurons throughout the hippocampal layers showed
SIVA-1-immunostaining (Fig. 2h, o–q). To confirm the
localization of SIVA-1 in neurons, P5 and P15 sections were
double immuno-labeled with SIVA-1 and the neuron-
specific marker NeuN. This approach revealed an almost
complete co-localization of both markers at all the devel-
opmental stages analyzed (Fig. 2i–k). Double immuno-
fluorescent studies with the astroglial cell marker Glial
fibrillary acidic protein (GFAP) did not show co-localization
with SIVA-1 (Fig. 2l–n). Finally, by double immunodetec-
tion of SIVA-1 with a specific interneuron subtype marker,
parvalbumin (PV), we confirmed the presence of SIVA-1 in
hippocampal neurons (Fig. 2o–q). We concluded that SIVA-
1 protein is predominantly expressed in developing and
adult neurons.
To determine the subcellular localization of SIVA-1, we
performed immunocytochemistry in primary cultures of
hippocampal neurons. We analyzed SIVA-1 distribution in
the cell body, performing co-localization analysis with sev-
eral organelle markers (i.e., MitoTracker for mitochondria,
Rab5 for early endosome, Calnexin for endoplasmic reticu-
lum; Fig. 3a). Manders co-localization coefficients were
obtained for each marker (Fig. 3b) and only values higher
than 0.5 were considered to indicate co-localization. SIVA-1
showed a mainly cytosolic distribution and co-localized with
markers of the cytoplasmic membrane (TrkA; M1= 0.68 ±
0.02), endocytic vesicles (Rab5; M1= 0.66 ± 0.15), and
cytoskeleton (βIII-tubulin; M1 0.71 ± 0.14). SIVA-1 did not
localize to mitochondria (MitoTracker; M1= 0.41 ± 0.04) or
to the endoplasmic reticulum (Calnexin; M1= 0.22 ± 0.15).
SIVA-1 expression was clearly excluded from the nucleus
(Hoechst staining; M1= 0.06 ± 0.03) (Fig. 3a, b). A sub-
cellular protein fractionation assay confirmed the localiza-
tion of SIVA-1 in cytosolic and light membrane fractions. As
expected FAIM-L also was found in cytosolic fraction (Fig.
3c). We also examined SIVA-1 co-localization with synaptic
markers in the neurites of 14 DIV hippocampal neurons and
found that SIVA-1 can also locate in presynaptic and post-
synaptic terminals as indicated by a positive correlation of
SIVA-1 immunostaining with both PDS95 and synapsin II
(Fig. 3d).
Taken together, our data indicate that SIVA-1 is
expressed in the cytoplasm of neurons during develop-
ment and adult stages. Co-expression of FAIM-L and
SIVA-1 in adult neurons in basal conditions suggests
that the latter participates in physiological nonlethal
processes.
SIVA-1 induces XIAP ubiquitination
XIAP is a potent inhibitor of effector caspases. Its ubi-
quitination and degradation by the proteasome is crucial
for caspase activation and induction of apoptosis9. FAIM-
L is a XIAP-interacting protein that executes its anti-
apoptotic function by inhibiting XIAP ubiquitination,
hence stabilizing its levels and inhibition on caspases.
Having reported SIVA-1 interaction with both proteins
we proceeded to address whether SIVA-1 interferes with
the FAIM-L/XIAP interaction and XIAP ubiquitination.
To this end, we analyzed the FAIM-L/XIAP interaction in
the presence of increasing amounts of overexpressed SIVA-
1 in PC12 cells (Fig. 4a, lanes 4–6). We performed an
immunoprecipitation of Myc-XIAP and found the amount
of co-immunoprecipitated FAIM-L to be inversely corre-
lated to SIVA-1 overexpression. Our results thus suggest
that SIVA-1 reduces the interaction of FAIM-L with XIAP.
Figure 4b shows ubiquitin immunoprecipitation in
HEK293T cells overexpressing HA-tagged SIVA-1,
FAIM-L, or a combination of both proteins. XIAP pre-
sented basal endogenous ubiquitination, which was
enhanced in the presence of SIVA-1 overexpression.
FAIM-L overexpression on the other hand reduced XIAP
ubiquitination levels, thereby confirming our previous
findings10. Moreover, overexpression of FAIM-L partially
restored SIVA-1-induced XIAP ubiquitination. Overall,
our results suggest that SIVA-1 and FAIM-L exert
opposite effects on XIAP ubiquitination levels.
SIVA-1 overexpression induces neuronal death by caspase-
3 activation
SIVA-1 was first reported as a proapoptotic protein, and
its overexpression has been shown to induce apoptosis in
various cell lines12,22–24.
(see figure on previous page)
Fig. 2 SIVA-1 is expressed in neurons during the development of the mouse brain. a At embryonic day 16 (E16), neurons in the cortical plate
(CP) and subplate (SP) contained SIVA-1. Scale bar 100 μm. b At postnatal day 5 (P5), SIVA-1-immunopositive cells were located throughout all cortical
layers. Scale bar 200 μm. c At postnatal day 15 (P15), SIVA-1-immunoreactive cells were present in all cortical layers. Note that cells located in layers
II–III showed intense SIVA-1-immunolabeling. Scale bar 200 μm. d In the cerebral cortex of adult mice, expression of SIVA-1 was restricted to cortical
cells in layer V. Scale bar 200 μm. e–g In the cerebellum, the soma and dendrites of Purkinje cells showed SIVA-1 immunostaining at all postnatal
stages analyzed. Scale bar 200 μm. h In the hippocampus, pyramidal neurons and hippocampal interneurons expressed SIVA-1. Some hippocampal
interneurons scattered in all hippocampal layers showed a strong immunostain (arrows in (h)). Scale bar 200 μm. i–k Double immunofluorescence of
SIVA-1 and NeuN (arrows) in cortical layer V at P5, showing an almost complete co-localization of the two markers. Scale bar 25 μm. l–n
Immunofluorescence co-localization of SIVA-1 and GFAP in cerebellum at P15 shows SIVA-1 expression in Purkinje cells (asterisks) but not in
astrocytes (arrowheads) in the cerebellum. Scale bar 25 μm. o–q Immunofluorescence co-localization of SIVA-1 and PV shows expression of SIVA-1 in
hippocampal interneurons (arrows). MZ marginal zone, IZ intermediate zone, SVZ subventricular zone, VZ ventricular zone, so stratum orines sp
stratum pyramidale, sr stratum radiatum, ML molecular layer, PCL Purkinje cell layer, GL granule cell layer.
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Here, we explored the effects of ectopic expression of
SIVA-1 in primary hippocampal neurons.
The overexpression of SIVA-1 was sufficient to induce
the typical hallmarks of apoptosis, such as chromatin
condensation and/or fragmentation, in 10% of the
neurons (Fig. 5a, b) respect to the empty vector, strong
cleavage of caspase-3 (Fig. 5c), and an evident increase in
caspase-3 activity (Fig. 5d). Treating cells with the pan-
caspase inhibitor Q-VD consistently abrogated SIVA-1-
induced apoptosis (Fig. 5a, b), thereby indicating that
SIVA-1 induces caspase-dependent cell death. Western
blot analysis of HA-SIVA-1 (Fig. 5e) and immunocy-
tochemistry analysis by counting GFP-positive cells
(Fig. 5f) confirmed SIVA-1 overexpression by lentiviral
vector in murine hippocampal neurons.
SIVA-1 modulates GluA2 internalization in hippocampal
neurons
XIAP and FAIM-L modulate the non-apoptotic function
of caspases, such as AMPAR GluA2 subunit internalization,
the main mechanism of chLTD4,11,25. We found that SIVA-
1 interacts with both XIAP and FAIM-L, and is an activator
of caspases. We therefore proceeded to analyze whether
SIVA-1 also regulates this plasticity process.
We performed a GluA2 internalization assay. Although
no change was detected in SIVA-1-overexpressing neu-
rons once NMDA treatment had been applied to induce
chLTD, we found that the sole ectopic expression of
SIVA-1 was sufficient to induce an increase in the inter-
nalization levels of the endogenous AMPAR subunit
GluA2 (Fig. 6a–c) in neurons. SIVA-1-induced inter-
nalization was blocked by the overexpression of FAIM-L,
thereby confirming a functional interaction between these
two proteins. As previously described in Martinez-
Marmol et al.11, FAIM-L overexpression abrogated
GluA2 internalization induced by chLTD.
Given that caspases are essential for GluA2 inter-
nalization, we addressed whether the decrease in GluA2
basal surface level in SIVA-1-overexpressing neurons was
caspase-dependent. The presence of the pan-caspase
inhibitor Q-VD totally abrogated SIVA-1-induced inter-
nalization of GluA2 (Fig. 7a, b), indicating that SIVA-1
modulates postsynaptic receptor levels in a caspase-
dependent manner.
To further examine the role of SIVA-1 in the regula-
tion of synaptic receptor internalization, we knocked
(see figure on previous page)
Fig. 3 SIVA-1 has a mainly cytosolic distribution in neurons. a Representative confocal images of hippocampal neurons. At 7 days in vitro,
immunofluorescence was performed by staining with anti-SIVA-1 (green), Hoechst (nucleus marker, blue). MitoTracker (mitochondria marker), anti-
Rab5 (early endosome marker), anti-calnexin (ER marker), anti-β III Tubulin (cytoskeleton marker), and anti-TrkA (cytosolic membrane marker) were
stained in red. Scale bar 10 µm. b Graph represents Mander’s coefficients M1 corresponding to the channel 1 (SIVA-1) signal that co-located with the
channel 2 (cellular markers) signal. Only values higher than 0.5 were considered to indicate co-localization. c Subcellular protein fractionation assay of
adult mouse brain. Histone 3 antibody was used as a nuclear marker, GluA2 as a plasma membrane marker, anti-calnexin as reticular membrane
protein, cytochrome C as a mitochondrial protein, and GAPDH as a cytosolic protein. N nuclear fraction, HM heavy membrane fraction, LM light
membrane fraction, C cytosolic fraction. d Representative confocal images of hippocampal neurites. At 14 days in vitro, immunofluorescence was
performed by staining with anti-SIVA-1 (green), presynaptic markers synapsin II (red) postsynaptic marker PSD95 (blue). The graph represents
Mander’s coefficient corresponding to co-localization between SIVA-1 and the synaptic markers. SIVA-1 was found to locate in some of the synapses
(arrows and asterisks). Scale bar 2 µm.
Fig. 4 SIVA-1 promotes XIAP ubiquitination. a PC12 cells were
transiently transfected with Myc-XIAP, FLAG-FAIM-L, and two
concentrations of HA-SIVA-1. Myc-XIAP was immunoprecipitated
using anti-Myc antibody. The membrane was blotted with anti-FLAG
to detect FAIM-L and anti-HA to detect SIVA-1. The antibody against
XIAP was used as a control of the immunoprecipitation and anti-
tubulin as loading control. b Cells were transfected with FAIM-L and
SIVA-1 (HA-SIVA-1), and endogenous ubiquitin was
immunoprecipitated using anti-ubiquitin antibody. The membrane
was blotted with FAIM-L, XIAP, and HA to detect SIVA-1, and tubulin
was used as a loading control.
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down SIVA-1 levels and analyzed GluA2 internalization.
A decrease in SIVA-1 levels was observed when a
shRNA was used (Fig. 7e). Although no change was
observed in untreated cells, we did detect a decrease in
GluA2 internalization in shSIVA-1-infected neurons
after the induction of chLTD. GluA2-induced inter-
nalization was marked in shSIVA-1 neurons, but sig-
nificantly decreased compared to control infected
neurons.
SIVA-1 levels are upregulated in chLTD induction
Our findings suggest a role of SIVA-1 in caspase-
dependent GluA2 internalization. The expression of sev-
eral modulators of synaptic plasticity is required for the
correct induction and maintenance of plasticity changes26.
Analysis of SIVA-1 protein levels during chLTD induction
showed that they were rapidly induced after 5min of
NMDA treatment (Fig. 8a, b), while SIVA-1 mRNA levels
were unaltered (Fig. 8c). The inhibition of protein
Fig. 5 SIVA-1 induces caspase-3-dependent cell death in neurons. Primary hippocampal neurons were infected for 72 h with lentiviral particles
carrying HA-SIVA-1 plasmid. a Representative images of Hoechst staining in control and overexpressing cells in the absence or presence of Q-VD,
scale bar 20 µm. b Quantification of the percentage of nuclei with apoptotic morphology by Hoechst staining. SIVA-1 induced apoptosis, Q-VD
treatment rescued cells from SIVA-1-induced cell death. Two-way ANOVA (empty vector vs. SIVA-1, F (1, 36)= 8.537 in untreated condition; F (1, 36)
= 7.787 in Q-VD condition) *p ≤ 0.05. c Treatment with 10 µM of pan-caspase inhibitor Q-VD abrogated caspase-3 cleavage. The membrane was
immunoblotted with anti-caspase-3 and anti-tubulin as a loading control. d DEVDase activity was measured in cells overexpressing SIVA-1 or control
empty vector. SIVA-1 induced the activation of caspase-3 (F (1, 8)= 38.69). Q-VD treatment abrogated caspase-3 activity (F (1, 8)= 289.9) UT
untreated, Q-VD quinolyl-Val-Asp-OPh. Two-way ANOVA *p ≤ 0.05; ***p ≤ 0.001. e SIVA-1 expression verified by western blot. HA was used to detect
SIVA-1; tubulin was used as a loading control. f Immunocytochemistry of SIVA-1 and GFP to confirm lentiviral transfection and overexpression.
Hoechst staining was used as a nuclear marker. Scale bar 10 µm.
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translation by cycloheximide blocked the increment of
SIVA-1 (Fig. 8d), thereby suggesting posttranscriptional
regulation.
Induction of chLTD by NMDA stimulation leads to an
increase in Ca2+ inflow in neurons, followed by calci-
neurin and caspase-3 activation, and the internalization of
AMPAR. Blockage of calcium by BAPTA-AM treatment
inhibited the increase in SIVA-1 expression after chLTD.
This observation thus suggests that the first steps of the
NMDA stimulation pathways are essential for SIVA-1
induction (Fig. 8d).
In conclusion, we propose SIVA-1 as a new modulator
of synaptic plasticity. We demonstrate that SIVA-1 is
increased in chLTD, where it activates caspase-3. We
propose that SIVA-1, by modulating the FAIM-L/XIAP
interaction, induces XIAP degradation and consequent
activation of caspases. SIVA-1 therefore emerges as a
novel regulator of caspase-dependent apoptotic and non-
apoptotic functions in neurons (Fig. 8e).
Discussion
Apoptosis is an essential process for the homeostasis of
organisms. It is subjected to multiple and tight mechan-
isms of regulation, but it can also be unscheduled trig-
gered in pathological processes such as degenerative
diseases. In these pathologies, the mechanisms of cellular
protection (i.e., antiapoptotic mechanisms) fail. Under-
standing the underlying components of the dysregulation
may provide new opportunities for therapeutic interven-
tion. The disassembly of neuronal integrity during cell
death is regulated by cysteine-aspartic acid proteases
called caspases. These proteins have been widely char-
acterized for their role in apoptosis27 and in non-
apoptotic functions. In neurons, caspases locate in den-
drites, axons, and in presynaptic and postsynaptic term-
inals. At these sites, they can be locally activated4 and
participate in synaptic plasticity and growth cone motility,
among other non-apoptotic functions28.
FAIM-L is a neuron-specific death receptor antagonist
that protects neurons against a variety of neurotoxic
insults6,8,10,29. We have reported that FAIM-L protects
XIAP, an inhibitor of caspases, from ubiquitination and
degradation. By stabilizing XIAP levels, FAIM-L regulates
caspase-3 activation in apoptosis and exerts non-
apoptotic functions11. To characterize FAIM-L in depth,
we performed a two-hybrid assay to detect interacting
proteins.
We identified and confirmed SIVA-1 to be a functional
partner of FAIM-L. SIVA-1 was first reported as a CD27-
interacting protein12. SIVA-1 plays a critical proapoptotic
role in several cellular types and is overexpressed in var-
ious pathological circumstances, such as ischemic injury
and Coxsakie virus B3 infection14,30–32. Resch et al.13
demonstrated that SIVA-1 interacts with XIAP, and
suggested that the interaction leads to mutual interference
with their action.
Our analysis of SIVA-1 expression and distribution in
brain tissues at embryonic and adult stages shows that this
protein is expressed in both developing and adult neu-
rons. Nervous system development requires a precise
regulation of programmed cell death, and many apoptotic
proteins have been found to be crucial. Among these,
SIVA-1 appears to play a key role during development, as
its deletion has been reported to result in embryonic
lethality in mice33. The presence of SIVA-1 expression is
maintained in adult cortical and hippocampal neurons,
thereby suggesting that this protein contributes to neu-
ronal physiological functions.
We examined the subcellular distribution of SIVA-1
in primary hippocampal neurons. Previous studies car-
ried out in various cell types reported controversial
findings on the subcellular localization of this protein.
Some described that the ectopic expression of SIVA-1
accumulates in the nucleus24,34,35 and that it can inter-
act with cell surface membrane receptors12,23,24,34.
Moreover, Jacobs et al.14 reported membrane localiza-
tion of SIVA-1 upon DNA-damage induced in the brain.
However, most of the functions exerted by SIVA-1 in
apoptosis take place in the cytoplasm36. Our analysis
shows that, in cultured hippocampal neurons, SIVA-1 is
located in cellular bodies, neurites and also in synapses,
and that it presents a diffuse cytosolic pattern that
excludes the nucleus, similar to the localization pattern
described for FAIM-L.
(see figure on previous page)
Fig. 6 SIVA-1 promotes GluA2 internalization. a Representative confocal images of neurons transfected with SIVA-1, FAIM-L, or empty vector.
GluA2 internalization assay was performed in neurons treated with NMDA to stimulate LTD and in untreated neurons. Only GFP-positive cells (first
column) were considered for quantification. Internalized GluA2 (second column, red in merge) and surface GluA2 (third column, green in merge)
were measured. Scale bar 10 µm. b Results were normalized to empty vector, untreated cells. Induction of chemical LTD induced GluA2
internalization in empty vector condition and SIVA-1 transfected cells (F (1, 632)= 15.85). Non-stimulated cells overexpressing SIVA-1 showed an
increase in GluA2 internalization. FAIM-L overexpression blocked LTD induction (F (3, 632)= 15.17), and its overexpression with SIVA-1 in untreated
cells restored basal levels of receptor internalization (F (3, 632)= 15.85). Each point represents an independent experimental repeat in which 15–20
cells were analyzed. UT untreated, NMDA N-methyl-D-aspartate. c GluA2 surface receptor was isolated with the Biotin surface assay in hippocampal
cells transfected with SIVA-1 or empty vector as a control. Lower panel shows quantification of GluA2 surface receptor (t (2)= 3,060). Two-way
ANOVA *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.0001.
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Fig. 7 SIVA-1 modulates AMPAR internalization in a caspase-dependent manner. a Representative confocal images of neurons transfected with
SIVA-1 or empty vector and treated with 10 μM of Q-VD (caspase inhibitor). Only GFP-positive cells (first column) were considered for quantification
(left panel). Scale bar 10 µm. b The results of the quantification of internalized GluA2 vs. surface GluA2 were normalized to empty vector, untreated
cells (right panel). Each point represents an independent experimental repeat in which 15–20 cells were analyzed. SIVA-1-transfected cells showed
greater internalization of GluA2 receptor (F (1, 97)= 3.840), Q-VD treatment restored internalization to basal levels (F (1, 97)= 7.345). Two-way ANOVA
***p ≤ 0.001. c Representative confocal images of neurons transfected with vectors carrying shSIVA-1 or shScramble as control. The GluA2
internalization assay was performed in neurons treated with NMDA to stimulate LTD and in untreated neurons. Only GFP-positive cells (first column)
were considered for quantification. Internalized GluA2 (second column, red in merge) and surface GluA2 (third column, green in merge) were
measured. Scale bar 10 µm. d The results of the quantification of internalized GluA2 vs. surface GluA2 were normalized to shScrambled, untreated
cells. Each point represents an independent experimental repeat in which 15–20 cells were analyzed. NMDA treatment induced GluA2 internalization
in both shScrambled and shSIVA-1 cells (F (1, 84)= 167.1). However, shSIVA-1 cells treated with NMDA showed a significant decrease in receptor
internalization (F (1, 84)= 33.5). Two-way ANOVA **p ≤ 0.01; ***p ≤ 0.001. shScr shScrambled.
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We then analyzed the possible functions of SIVA-1 in
relation to the previously described FAIM-L function on
XIAP modulation10,11. Our data show that SIVA-1 over-
expression displaces the FAIM-L/XIAP interaction. Loss of
interaction with FAIM-L can be sufficient to promote XIAP
instability, thereby inducing ubiquitination-mediated pro-
teasomal degradation. We reveal that SIVA-1 over-
expression also has a direct effect on promoting XIAP
ubiquitination. Given that SIVA-1 is a XIAP-interacting
protein, it might confer structural changes to XIAP that
permit auto-ubiquitination, or it may serve as an ubiquitin
ligase on XIAP. In fact, SIVA-1 has been described to have
E3 ubiquitin ligase activity and to direct E3 ubiquitin ligases
to promote the ubiquitination of other proteins and con-
sequent changes in their function or stability37,38. In a
complex process such as apoptosis, which involves hun-
dreds of molecules, the regulation between proapoptotic
and antiapoptotic proteins is common and can often be
mediated by ubiquitination39.
Here, we report the proapoptotic activity of SIVA-1 in
primary cultures of hippocampal neurons. SIVA-1 over-
expression is sufficient to induce apoptosis through
effector caspase activation. We propose that the promo-
tion of cell death induced by SIVA-1 overexpression
occurs through XIAP destabilization and consequent
inhibition of XIAP action on effector caspases. Here we
provide evidence that SIVA-1 participates in XIAP mod-
ulation and apoptosis and that it exerts the opposite
function to FAIM-L.
We addressed whether SIVA-1 has a neuron-specific
non-apoptotic role. We demonstrate that SIVA-1 is
expressed in cultured hippocampal neurons in the absence
of proapoptotic stimuli. This finding points to a non-
apoptotic role of the protein. We studied LTD, a well
characterized caspase-dependent mechanism, which
requires a controlled activation of the same mitochondrial
pathway and that involves the same proteins that can lead
to apoptotic cell death. Many apoptotic regulatory proteins
modulate caspase activation in synaptic depression, and
among these we find both FAIM-L and XIAP as inhibitors
of the process. We used as a model for our study the
extensively described chLTD. After NMDA stimulation,
chLTD is induced. A rapid increase in calcium levels is
triggered by NMDA receptor activation, followed by an
involvement of calcineurin and caspase-3. The activation
culminates in AMPAR internalization and therefore
synaptic weakening40. When measuring surface AMPAR
levels in our cellular primary cultures, we observed that
SIVA-1 induces an increase in GluA2 internalization in
non-stimulated neurons in a caspase-dependent manner.
Moreover, SIVA-1 knockdown significantly decreases
receptor internalization following chLTD. Therefore SIVA-
1 emerges as another regulator of apoptosis that is also
required for functions not related to cell death. FAIM-L
overexpression abrogates GluA2 internalization following
chLTD and also restores SIVA-1 induction of GluA2
internalization in hippocampal neurons.
Protein composition at synapses is modulated in response
to neuronal activity, through new synthesis and
removal41,42. We show an increase in SIVA-1 protein levels
in primary cultures after a few minutes of NMDA treat-
ment. The increase is blocked by cycloheximide and does
not affect SIVA-1 mRNA levels, thereby indicating specific
translational regulation. The increase in SIVA-1 could be
directly associated with NMDA receptor stimulation after
treatment, since a calcium chelating agent, BAPTA-AM,
blocks this increase. BAPTA-AM pretreatment has been
reported to block LTD induction, thus eliminating available
calcium ions to start a stimulation response after NMDA or
electrical application43,44. The enhanced SIVA-1 expression
in chLTD supports the relevance of this protein in the
modulation of this synaptic plasticity mechanism.
In summary, our results reveal novel key roles of SIVA-
1 in neurons. We show that SIVA-1 interacts with both
FAIM-L and XIAP and that it is also a caspase activator.
We associate SIVA-1-induced caspase activation with
neural apoptosis, which is consistent with its previously
described functions. Moreover, we demonstrate a novel
function of SIVA-1 as regulator of synaptic function.
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Fig. 8 Levels of SIVA-1 increase after NMDA treatment. a Primary neuronal cells were treated with 50 μM of NMDA at different time points
(0–30 min) and protein expression of SIVA-1 was analyzed by SDS-PAGE. Anti-tubulin was used as a loading control. b SIVA-1 expression increased
with 5 min, and 15min treatment of NMDA. t test (t (15)= 2427; t(15)= 2755). *p ≤ 0.05. c qPCR revealed no change in SIVA-1 mRNA expression after
treatment. d The increase in SIVA-1 levels (two-way ANOVA F(2, 6)= 1712) was blocked by pretreatments with 50 µM of BAPTA-AM for 30 min or
1 µg/ml of cycloheximide for 1 h (two-way ANOVA (F (3, 9)= 1326)). *p ≤ 0.05 for comparison between time points in the same treatment, #p ≤ 0.05
for comparison between treatments. e Schematic representation of SIVA-1 function. In neurons, SIVA-1 was increased after chemical LTD induction.
SIVA-1 destabilized XIAP by increasing its ubiquitination and impairing its interaction with FAIM-L. We propose that this is one of the mechanisms
through which SIVA-1 triggers caspase-3 activation in neurons and consequent apoptosis and caspase-3-dependent GluA2 internalization. CHX
cycloheximide, BAPTA-AM 1,2-Bis(2-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid tetrakis(acetoxymethyl ester), chLTD chemical long-term
depression.
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